|
1
|
Bochtler T, Löffler H and Krämer A:
Diagnosis and management of metastatic neoplasms with unknown
primary. Semin Diagn Pathol. 35:199–206. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abbruzzese JL, Abbruzzese MC, Hess KR,
Raber MN, Lenzi R and Frost P: Unknown primary carcinoma: Natural
history and prognostic factors in 657 consecutive patients. J Clin
Oncol. 12:1272–1280. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pavlidis N and Pentheroudakis G: Cancer of
unknown primary site. Lancet. 379:1428–1435. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bochtler T and Krämer A: Does cancer of
unknown primary (CUP) truly exist as a distinct cancer entity?
Front Oncol. 9:4022019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pauli C, Bochtler T, Mileshkin L,
Baciarello G, Losa F, Ross JS, Pentheroudakis G, Zarkavelis G,
Yalcin S, Özgüroğlu M, et al: A challenging task: Identifying
patients with cancer of unknown primary (CUP) according to ESMO
guidelines: The CUPISCO trial experience. Oncologist. 26:e769–e779.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tay J and Dewdney A: Cancers of unknown
primary. Br J Hosp Med (Lond). 80:C70–C74. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Piga A, Gesuita R, Catalano V, Nortilli R,
Cetto G, Cardillo F, Giorgi F, Riva N, Porfiri E, Montironi R, et
al: Identification of clinical prognostic factors in patients with
unknown primary tumors treated with a platinum-based combination.
Oncology. 69:135–144. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Keller F, Psychogios G, Linke R, Lell M,
Kuwert T, Iro H and Zenk J: Carcinoma of unknown primary in the
head and neck: Comparison between positron emission tomography
(PET) and PET/CT. Head Neck. 33:1569–1575. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fizazi K, Greco FA, Pavlidis N and
Pentheroudakis G; ESMO Guidelines Working Group, : Cancers of
unknown primary site: ESMO clinical practice guidelines for
diagnosis, treatment and follow-up. Ann Oncol. 26:S133–S138. 2015.
View Article : Google Scholar
|
|
10
|
Gucalp A, Traina TA, Eisner JR, Parker JS,
Selitsky SR, Park BH, Elias AD, Baskin-Bey ES and Cardoso F: Male
breast cancer: A disease distinct from female breast cancer. Breast
Cancer Res Treat. 173:37–48. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ronchi A, Pagliuca F, Marino FZ, Accardo
M, Cozzolino I and Franco R: Current and potential
immunohistochemical biomarkers for prognosis and therapeutic
stratification of breast carcinoma. Semin Cancer Biol. 72:114–122.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Conner JR and Hornick JL: Metastatic
carcinoma of unknown primary: Diagnostic approach using
immunohistochemistry. Adv Anat Pathol. 22:149–167. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Krämer A, Hübner G, Schneeweiss A,
Folprecht G and Neben K: Carcinoma of unknown primary-an orphan
disease? Breast Care (Basel). 3:164–170. 2008.PubMed/NCBI
|
|
14
|
National Cancer Registration and Analysis
Service, . Routes to Diagnosis. Cancer of Unknown Primary.
2010.Available from:. http://ncin.org.uk/publications/data_briefings/routes_to_diagnosis_cancer_of_unknown_primary12–December.
2018
|
|
15
|
De Andrade JM, Marana HR, Filho JM, Murta
EF, Velludo MA and Bighetti S: Differential diagnosis of axillary
masses. Tumori. 82:596–599. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gupta RK, Naran S, Lallu S and Fauck R:
Diagnostic value of needle aspiration cytology in the assessment of
palpable axillary lymph nodes. A study of 336 cases. Acta Cytol.
47:550–554. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Blanchard DK and Farley DR: Retrospective
study of women presenting with axillary metastases from occult
breast carcinoma. World J Surg. 28:535–539. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Baron PL, Moore MP, Kinne DW, Candela FC,
Osborne MP and Petrek JA: Occult breast cancer presenting with
axillary metastases. Updated management. Arch Surg. 125:210–214.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Galimberti V, Bassani G, Monti S, Simsek
S, Villa G, Renne G and Luini A: Clinical experience with axillary
presentation breast cancer. Breast Cancer Res Treat. 88:43–47.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Walker GV, Smith GL, Perkins GH, Oh JL,
Woodward W, Yu TK, Hunt KK, Hoffman K, Strom EA and Buchholz TA:
Population-based analysis of occult primary breast cancer with
axillary lymph node metastasis. Cancer. 116:4000–4006. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mann RM, Balleyguier C, Baltzer PA, Bick
U, Colin C, Cornford E, Evans A, Fallenberg E, Forrai G, Fuchsjäger
MH, et al: European society of breast imaging (EUSOBI), with
language review by Europa Donna-The European breast cancer
coalition. Breast MRI: EUSOBI recommendations for women's
information. Eur Radiol. 25:3669–3678. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stella GM, Senetta R, Cassenti A, Ronco M
and Cassoni P: Cancers of unknown primary origin: Current
perspectives and future therapeutic strategies. J Transl Med.
10:122012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sardanelli F, Boetes C, Borisch B, Decker
T, Federico M, Gilbert FJ, Helbich T, Heywang-Köbrunner SH, Kaiser
WA, Kerin MJ, et al: Magnetic resonance imaging of the breast:
Recommendations from the EUSOMA working group. Eur J Cancer.
46:1296–1316. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Parisi S, Ruggiero R, Gualtieri G, Volpe
ML, Rinaldi S, Nesta G, Bogdanovich L, Lucido FS, Tolone S,
Parmeggiani D, et al: Combined LOCalizer™ and intraoperative
ultrasound localization: First experience in localization of
non-palpable breast cancer. In Vivo. 35:1669–1676. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Parisi S, Gambardella C, Ruggiero R,
Tolone S, Lucido FS and Docimo L: Radiofrequency
identification-RFID using LOCalizer-tag in non-palpable breast
lump. Indian J Surg. 85:934–938. 2023. View Article : Google Scholar
|
|
26
|
Iovino F, Diana A, Carlino F, Ferraraccio
F, Antoniol G, Fisone F, Perrone A, Marino FZ, Panarese I, Tathode
MS, et al: Expression of c-MET in estrogen receptor positive and
HER2 negative resected breast cancer correlated with a poor
prognosis. J Clin Med. 11:69872022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Takeyama H, Takahashi H, Tabei I, Fukuchi
O, Nogi H, Kinoshita S, Uchida K and Morikawa T: Malignant neoplasm
in the axilla of a male: Suspected primary carcinoma of an
accessory mammary gland. Breast Cancer. 17:151–154. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liberati A, Altman DG, Tetzlaff J, Mulrow
C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J
and Moher D: The PRISMA statement for reporting systematic reviews
and meta-analyses of studies that evaluate healthcare
interventions: Explanation and elaboration. BMJ. 339:b27002009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kuninaka K, Takahashi R, Nakagawa Y and
Nishimaki T: A case of HER2-positive male occult breast carcinoma
with skin and lymph node metastases that exhibited complete
response to trastuzumab monotherapy. Clin Case Rep. 5:591–593.
2017. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sood N, Gupta R and Gupta S: Invasive
solid papillary carcinoma: Report of the first case presenting as
an occult breast carcinoma in a male. Indian J Pathol Microbiol.
63:S141–S142. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gu GL, Wang SL, Wei XM, Ren L and Zou FX:
Axillary metastasis as the first manifestation of occult breast
cancer in a male patient. Breast Care (Basel). 4:43–45. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang WW, Chen L and Ouyang XN:
Misdiagnosed male breast cancer with an unknown primary tumor: A
case report. Oncol Lett. 8:190–192. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang X, Fan L, Yan W, Zhang Q, Bao S, Wang
Y, Bao X and Liu L: Axillary lymph node metastasis as the first
manifestation of male occult breast cancer: A case report. Medicine
(Baltimore). 97:e137062018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang L, Zhang C, Yang Z, He M, Zhang L,
Ezzat S and Liang X: Male occult triple-negative breast cancer with
dermatomyositis: A case report and review of the literature. Onco
Targets Ther. 10:5459–5462. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hur SM, Cho DH, Lee SK, Choi MY, Bae SY,
Koo MY, Kim S, Nam SJ, Lee JE and Yang JH: Occult breast cancers
manifesting as axillary lymph node metastasis in men: A two-case
report. J Breast Cancer. 15:359–563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gu GL, Wang SL, Wei XM, Ren L and Zou FX:
Axillary metastasis as the first manifestation of male breast
cancer: A case report. Cases J. 30:2852008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
He M, Liu H and Jiang Y: A case report of
male occult breast cancer first manifesting as axillary lymph node
metastasis with part of metastatic mucinous carcinoma. Medicine
(Baltimore). 94:e10382015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu R, Li J, Zhang Y, Jing H and Zhu Y:
Male occult breast cancer with axillary lymph node metastasis as
the first manifestation: A case report and literature review.
Medicine (Baltimore). 96:e93122017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rigakos G, Vakos A, Papadopoulos S,
Vernadou A, Tsimpidakis A, Papachristou D and Razis E: Cancer of
unknown primary ultimately diagnosed as male breast cancer: A rare
case report. Mol Clin Oncol. 5:263–266. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Varadhachary GR, Spector Y, Abbruzzese JL,
Rosenwald S, Wang H, Aharonov R, Carlson HR, Cohen D, Karanth S,
Macinskas J, et al: Prospective gene signature study using microRNA
to identify the tissue of origin in patients with carcinoma of
unknown primary. Clin Cancer Res. 17:4063–4070. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pentheroudakis G, Pavlidis N, Fountzilas
G, Krikelis D, Goussia A, Stoyianni A, Sanden M, St Cyr B,
Yerushalmi N, Benjamin H, et al: Novel microRNA-based assay
demonstrates 92% agreement with diagnosis based on
clinicopathologic and management data in a cohort of patients with
carcinoma of unknown primary. Mol Cancer. 12:572013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rosenwald S, Gilad S, Benjamin S, Lebanony
D, Dromi N, Faerman A, Benjamin H, Tamir R, Ezagouri M, Goren E, et
al: Validation of a microRNA-based qRT-PCR test for accurate
identification of tumor tissue origin. Mod Pathol. 23:814–823.
2010. View Article : Google Scholar : PubMed/NCBI
|
